SOCS1-based therapeutic peptides improve liver disease and metabolic dysfunction in obesity and diabetes.

Sci Rep · 2026 · PMC13219389 · PMID 41957073

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

3 E), and showed a trend toward reduced inflammatory clusters (Fig. 3 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.